In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells

Very recently, we postulated that the incorporation of citral into nanostructured lipid carrier (NLC-Citral) improves solubility and delivery of the citral without toxic effects in vivo. Thus, the objective of this study is to evaluate anti-cancer effects of NLC-Citral in MDA MB-231 cells in vitro t...

Full description

Bibliographic Details
Main Authors: Nordin, Noraini, Yeap, Swee Keong, Muhammad, Heshu Sulaiman Rahman, Zamberi, Nur Rizi, Abu, Nadiah, Mohamad, Nurul Elyani, Chee, Wun How, Masarudin, Mas Jaffri, Abdullah, Rasedee @ Mat, Mohammed Alitheen, Noorjahan Banu
Format: Article
Language:English
Published: Nature Publishing Group 2019
Online Access:http://psasir.upm.edu.my/id/eprint/80222/
http://psasir.upm.edu.my/id/eprint/80222/1/In%20vitro%20cytotoxicity%20and%20anticancer%20effects%20of%20citral%20nanostructured%20lipid%20carrier%20on%20MDA%20MBA-231%20human%20breast%20cancer%20cells.pdf
_version_ 1848858861667090432
author Nordin, Noraini
Yeap, Swee Keong
Muhammad, Heshu Sulaiman Rahman
Zamberi, Nur Rizi
Abu, Nadiah
Mohamad, Nurul Elyani
Chee, Wun How
Masarudin, Mas Jaffri
Abdullah, Rasedee @ Mat
Mohammed Alitheen, Noorjahan Banu
author_facet Nordin, Noraini
Yeap, Swee Keong
Muhammad, Heshu Sulaiman Rahman
Zamberi, Nur Rizi
Abu, Nadiah
Mohamad, Nurul Elyani
Chee, Wun How
Masarudin, Mas Jaffri
Abdullah, Rasedee @ Mat
Mohammed Alitheen, Noorjahan Banu
author_sort Nordin, Noraini
building UPM Institutional Repository
collection Online Access
description Very recently, we postulated that the incorporation of citral into nanostructured lipid carrier (NLC-Citral) improves solubility and delivery of the citral without toxic effects in vivo. Thus, the objective of this study is to evaluate anti-cancer effects of NLC-Citral in MDA MB-231 cells in vitro through the Annexin V, cell cycle, JC-1 and fluorometric assays. Additionally, this study is aimed to effects of NLC-Citral in reducing the tumor weight and size in 4T1 induced murine breast cancer model. Results showed that NLC-Citral induced apoptosis and G2/M arrest in MDA MB-231 cells. Furthermore, a prominent anti-metastatic ability of NLC-Citral was demonstrated in vitro using scratch, migration and invasion assays. A significant reduction of migrated and invaded cells was observed in the NLC-Citral treated MDA MB-231 cells. To further evaluate the apoptotic and anti-metastatic mechanism of NLC-Citral at the molecular level, microarray-based gene expression and proteomic profiling were conducted. Based on the result obtained, NLC-Citral was found to regulate several important signaling pathways related to cancer development such as apoptosis, cell cycle, and metastasis signaling pathways. Additionally, gene expression analysis was validated through the targeted RNA sequencing and real-time polymerase chain reaction. In conclusion, the NLC-Citral inhibited the proliferation of breast cancer cells in vitro, majorly through the induction of apoptosis, anti-metastasis, anti-angiogenesis potentials, and reducing the tumor weight and size without altering the therapeutic effects of citral.
first_indexed 2025-11-15T12:20:10Z
format Article
id upm-80222
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T12:20:10Z
publishDate 2019
publisher Nature Publishing Group
recordtype eprints
repository_type Digital Repository
spelling upm-802222020-10-05T01:45:26Z http://psasir.upm.edu.my/id/eprint/80222/ In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells Nordin, Noraini Yeap, Swee Keong Muhammad, Heshu Sulaiman Rahman Zamberi, Nur Rizi Abu, Nadiah Mohamad, Nurul Elyani Chee, Wun How Masarudin, Mas Jaffri Abdullah, Rasedee @ Mat Mohammed Alitheen, Noorjahan Banu Very recently, we postulated that the incorporation of citral into nanostructured lipid carrier (NLC-Citral) improves solubility and delivery of the citral without toxic effects in vivo. Thus, the objective of this study is to evaluate anti-cancer effects of NLC-Citral in MDA MB-231 cells in vitro through the Annexin V, cell cycle, JC-1 and fluorometric assays. Additionally, this study is aimed to effects of NLC-Citral in reducing the tumor weight and size in 4T1 induced murine breast cancer model. Results showed that NLC-Citral induced apoptosis and G2/M arrest in MDA MB-231 cells. Furthermore, a prominent anti-metastatic ability of NLC-Citral was demonstrated in vitro using scratch, migration and invasion assays. A significant reduction of migrated and invaded cells was observed in the NLC-Citral treated MDA MB-231 cells. To further evaluate the apoptotic and anti-metastatic mechanism of NLC-Citral at the molecular level, microarray-based gene expression and proteomic profiling were conducted. Based on the result obtained, NLC-Citral was found to regulate several important signaling pathways related to cancer development such as apoptosis, cell cycle, and metastasis signaling pathways. Additionally, gene expression analysis was validated through the targeted RNA sequencing and real-time polymerase chain reaction. In conclusion, the NLC-Citral inhibited the proliferation of breast cancer cells in vitro, majorly through the induction of apoptosis, anti-metastasis, anti-angiogenesis potentials, and reducing the tumor weight and size without altering the therapeutic effects of citral. Nature Publishing Group 2019 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/80222/1/In%20vitro%20cytotoxicity%20and%20anticancer%20effects%20of%20citral%20nanostructured%20lipid%20carrier%20on%20MDA%20MBA-231%20human%20breast%20cancer%20cells.pdf Nordin, Noraini and Yeap, Swee Keong and Muhammad, Heshu Sulaiman Rahman and Zamberi, Nur Rizi and Abu, Nadiah and Mohamad, Nurul Elyani and Chee, Wun How and Masarudin, Mas Jaffri and Abdullah, Rasedee @ Mat and Mohammed Alitheen, Noorjahan Banu (2019) In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells. Scientific Reports, 9. art. no. 1614. pp. 1-19. ISSN 2045-2322 10.1038/s41598-018-38214-x
spellingShingle Nordin, Noraini
Yeap, Swee Keong
Muhammad, Heshu Sulaiman Rahman
Zamberi, Nur Rizi
Abu, Nadiah
Mohamad, Nurul Elyani
Chee, Wun How
Masarudin, Mas Jaffri
Abdullah, Rasedee @ Mat
Mohammed Alitheen, Noorjahan Banu
In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells
title In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells
title_full In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells
title_fullStr In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells
title_full_unstemmed In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells
title_short In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells
title_sort in vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on mda mba-231 human breast cancer cells
url http://psasir.upm.edu.my/id/eprint/80222/
http://psasir.upm.edu.my/id/eprint/80222/
http://psasir.upm.edu.my/id/eprint/80222/1/In%20vitro%20cytotoxicity%20and%20anticancer%20effects%20of%20citral%20nanostructured%20lipid%20carrier%20on%20MDA%20MBA-231%20human%20breast%20cancer%20cells.pdf